Seres Therapeutics (MCRB)
NASDAQ:MCRB
Holding MCRB?
Track your performance easily

Seres Therapeutics (MCRB) Technical Analysis

1,010 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Seres Therapeutics’s (MCRB) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Seres Therapeutics is a Sell.
Seres Therapeutics’s (MCRB) 20-Day exponential moving average is 0.81, while Seres Therapeutics’s (MCRB) share price is $0.807, making it a Buy.
Seres Therapeutics’s (MCRB) 50-Day exponential moving average is 0.87, while Seres Therapeutics’s (MCRB) share price is $0.807, making it a Sell.

Seres Therapeutics (MCRB) Pivot Points

Nov 05, 2024, 08:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.70
0.73
0.77
0.80
0.85
0.87
0.92
Fibonacci
0.73
0.76
0.77
0.80
0.83
0.84
0.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Seres Therapeutics (MCRB) Moving Averages

Nov 05, 2024, 08:27 AM
Period
Simple
Exponential
MA5
0.78Buy
0.79Buy
MA10
0.77Buy
0.78Buy
MA20
0.79Buy
0.81Buy
MA50
0.88Sell
0.87Sell
MA100
0.93Sell
0.91Sell
MA200
0.93Sell
0.95Sell
Seres Therapeutics’s (MCRB) 10-Day exponential moving average is 0.78, while Seres Therapeutics’s (MCRB) share price is $0.807, making it a Buy.
Seres Therapeutics’s (MCRB) 100-Day exponential moving average is 0.91, while Seres Therapeutics’s (MCRB) share price is $0.807, making it a Sell.
Seres Therapeutics’s (MCRB) stock price is $0.807 and Seres Therapeutics’s (MCRB) 50-day simple moving average is 0.88, creating a Sell signal.
Seres Therapeutics’s (MCRB) stock price is $0.807 and Seres Therapeutics’s (MCRB) 100-day simple moving average is 0.93, creating a Sell signal.
Seres Therapeutics’s (MCRB) stock price is $0.807 and Seres Therapeutics’s (MCRB) 200-day simple moving average is 0.93, creating a Sell signal.

Seres Therapeutics (MCRB) Technical Indicators

Nov 05, 2024, 08:27 AM
Name
Value
Implied Action
RSI (14)
49.68
Neutral
STOCH (9,6)
77.18
Neutral
STOCHRSI (14)
67.02
Neutral
MACD (12,26)
-0.03
Sell
ADX (14)
14.42
Buy
Williams %R
-25.93
Buy
CCI (14)
37.74
Neutral
ATR (14)
0.07
-
Ultimate Oscillator
46.40
Neutral
ROC
-2.38
Sell
Seres Therapeutics’s (MCRB) Relative Strength Index (RSI) is 49.68, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Trend Strength Indicator (ADX) is 14.42, creating a Buy signal.
Seres Therapeutics’s (MCRB) Commodity Channel Index (CCI) is 37.74, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Price Rate of Change (ROC) is -2.38, creating a Sell signal.

FAQ

Is MCRB a Buy, Hold, or Sell?
Based on MCRB’s technical indicators, MCRB is a Hold.
    What is MCRB’s RSI (14)?
    MCRB’s RSI (14) is 49.68, which suggests MCRB is a Neutral.
      What is MCRB’s MACD?
      MCRB’s MACD is -0.03, which suggests MCRB is a Sell.
        What is MCRB’s 5-day moving average?
        MCRB’s 5-day moving average is 0.78, which suggests MCRB is a Buy.
          What is MCRB’s 20-day moving average?
          MCRB 20-day moving average is 0.79, which suggests MCRB is a Buy.
            What is MCRB’s 50-day moving average?
            MCRB’s 50-day moving average is 0.88, which suggests MCRB is a Sell.
              What is MCRB’s 200-day moving average?
              MCRB’s 200-day moving average is 0.93, which suggests MCRB is a Sell.
                What is MCRB’s Williams % R (14)?
                MCRB’s Williams % R (14) is -25.93, which suggests MCRB is a Buy.
                  What is MCRB’s CCI (14)?
                  MCRB’s CCI (14) is 37.74, which suggests MCRB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis